Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants Under Fasting Conditions
Clinical trial NCT07606105 · RECRUITING
Trial details
- NCT number
- NCT07606105
- Sponsor
- Sichuan Huiyu Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-19
- Primary completion
- 2026-08-26
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.